Related Experiment Video
Updated: Aug 21, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations
Ricardo Caballero1, Ricardo Gómez, Lucía Núñez
1Department of Pharmacology, School of Medicine, Universidad Complutense, 28040 Madrid, Spain. rcaballero@ift.csic.es
Insights
Diltiazem, a common arrhythmia drug, blocks cardiac potassium channels hKv1.5 and Kv4.3. This study reveals diltiazem binds to open and inactivated states of these channels, impacting cardiac electrical activity.
Area of Science:
- Cardiovascular Pharmacology
- Ion Channel Physiology
- Cardiac Electrophysiology
Background:
- Diltiazem is a widely used L-type Ca(2+) channel blocker for supraventricular arrhythmias.
- Cardiac potassium channels, including hKv1.5 (I(Kur)) and Kv4.3 (I(to)), are crucial for cardiac action potential repolarization.
Purpose of the Study:
- To investigate the effects of diltiazem on human Kv1.5 (hKv1.5) and Kv4.3 potassium channels.
- To determine the mechanism of diltiazem's interaction with these specific cardiac ion channels.
Main Methods:
- Stable and transient expression of hKv1.5 and Kv4.3 channels in mammalian cell lines.
- Whole-cell patch-clamp electrophysiology to record potassium currents.
- Dose-response, frequency-dependent, and voltage-dependence analyses of channel block.
Main Results:
- Diltiazem exhibited frequency-dependent block of both hKv1.5 and Kv4.3 channels with biphasic dose-response curves.
- Blockade of hKv1.5 channels involved shifts in activation and inactivation curves.
- Diltiazem accelerated inactivation of Kv4.3 channels and shifted its inactivation voltage-dependence.
Conclusions:
- Diltiazem effectively reduces hKv1.5 and Kv4.3 currents.
- The drug binds to both open and inactivated states of hKv1.5 and Kv4.3 channels.
- These findings provide novel insights into diltiazem's electrophysiological effects at the channel level.
Objective:
In the present study we examined the effects of diltiazem, an L-type Ca(2+) channel blocker widely used for the control of the ventricular rate in patients with supraventricular arrhythmias, on hKv1.5 and Kv4.3 channels that generate the cardiac ultrarapid delayed rectifier (I(Kur)) and the 4-aminopyridine sensitive transient outward (I(to)) K(+) currents, respectively.
Methods:
hKv1.5 and Kv4.3 channels were stably and transiently expressed in mouse fibroblast and Chinese hamster ovary cells, respectively. Currents were recorded using the whole-cell patch clamp.
Results:
Diltiazem (0.01 nM-500 muM) blocked hKv1.5 channels, in a frequency-dependent manner exhibiting a biphasic dose-response curve (IC(50)=4.8+/-1.5 nM and 42.3+/-3.6 muM). Diltiazem delayed the initial phase of the tail current decline and shifted the midpoint of the activation (Vh=-16.5+/-2.1 mV vs -20.4+/-2.6 mV, P<0.001) and inactivation (Vh=-22.4+/-0.7 mV vs. -28.2+/-1.9 mV, P<0.001) curves to more negative potentials. The analysis of the development of the diltiazem-induced block yielded apparent association (k) and dissociation (P) rate constants of (1.6+/-0.2) x 10(6) M(-1)s(-1) and 46.8+/-4.8 s(-1), respectively. Diltiazem (0.1 nM-100 muM) also blocked Kv4.3 channels in a frequency-dependent manner exhibiting a biphasic dose-response curve (IC(50)=62.6+/-11.1 nM and 109.9+/-12.8 muM). Diltiazem decreased the peak current and, at concentrations > or =0.1 microM, accelerated the inactivation time course. The apparent association and dissociation rate constants resulted (1.7+/-0.2) x 10(6) M(-1)s(-1) and 258.6+/-38.1 s(-1), respectively. Diltiazem, 10 nM, shifted to more negative potentials the voltage-dependence of Kv4.3 channel inactivation (Vh=-33.1+/-2.3 mV vs -38.2+/-3.5 mV, n=6, Plt;0.05) the blockade increasing at potentials at which the amount of inactivated channels increased.
Conclusion:
The results demonstrated for the first time that diltiazem, at therapeutic concentrations, decreased hKv1.5 and Kv4.3 currents by binding to the open and the inactivated state of the channels.
More Related Videos
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
10:07High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
Related Concept Videos
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers